Ceftriaxone Dosing Recommendations
For adults with bacterial meningitis, use ceftriaxone 2 g IV every 12 hours; for children, use 100 mg/kg/day (max 4 g) which can be given once daily or divided every 12 hours; for uncomplicated gonococcal infections, use a single 500 mg IM dose in adults or 250 mg IM for uncomplicated urogenital gonorrhea.
Adult Dosing
Meningitis
- Standard empiric therapy: 2 g IV every 12 hours 1
- Duration:
- Special considerations: Add vancomycin 15-20 mg/kg IV every 12 hours if penicillin-resistant pneumococcus suspected (e.g., recent travel from high-resistance areas) 1
Gonococcal Infections
- Uncomplicated urogenital/anorectal/pharyngeal: Single 500 mg IM dose 2
- Disseminated gonococcal infection (DGI): 1 g IM or IV every 24 hours until 24-48 hours after improvement, then switch to oral therapy to complete 1 week 4
- Gonococcal meningitis: 1-2 g IV every 12 hours for 10-14 days 4
- Gonococcal endocarditis: 1-2 g IV every 12 hours for at least 4 weeks 4
General Infections
- Standard dose: 1-2 g IV/IM once daily or divided every 12 hours 5
- Maximum daily dose: 4 g 5
- Surgical prophylaxis: 1 g IV single dose 0.5-2 hours before surgery 5
Pediatric Dosing
Meningitis
- Initial dose: 100 mg/kg IV (max 4 g) 5
- Maintenance: 100 mg/kg/day (max 4 g daily), given once daily or divided every 12 hours 5
- Duration: 7-14 days 5
- Recent evidence: Once-daily dosing (100 mg/kg) achieves better early CSF penetration than twice-daily dosing (50 mg/kg every 12 hours) for MIC 1 mg/L organisms 6
Other Serious Infections
- Dose: 50-75 mg/kg/day, divided every 12 hours (max 2 g/day) 5
Acute Otitis Media
- Single dose: 50 mg/kg IM (max 1 g) 5
Skin/Soft Tissue Infections
- Dose: 50-75 mg/kg once daily or divided twice daily (max 2 g/day) 5
Neonatal Dosing
Critical Safety Warnings
- CONTRAINDICATED in premature neonates 5
- CONTRAINDICATED in neonates ≤28 days requiring calcium-containing IV solutions 5
- Infusion time: Give over 60 minutes (not 30 minutes) to reduce bilirubin encephalopathy risk 5
Age-Specific Dosing
- <1 week: Cefotaxime preferred over ceftriaxone; if ceftriaxone used: 50 mg/kg every 8 hours 7
- 1-4 weeks: 50 mg/kg every 6-8 hours 7
Special Populations
Renal/Hepatic Impairment
- No dose adjustment needed for doses up to 2 g/day 5
- Ceftriaxone is dual-eliminated (33-67% renal, remainder biliary) 5
- Not significantly removed by hemodialysis 5
Elderly
- No modification needed up to 2 g/day if no severe renal/hepatic impairment 5
Administration Guidelines
IV Administration
- Infusion time: 30 minutes in adults and children >28 days 5
- Neonates: 60 minutes mandatory 5
- Concentration: 10-40 mg/mL recommended 5
IM Administration
Critical Pitfalls
- Calcium interaction: Never mix with calcium-containing solutions (Ringer's, Hartmann's) - can cause fatal precipitation 5
- Neonatal hyperbilirubinemia: Ceftriaxone displaces bilirubin from albumin; avoid in jaundiced neonates 5
- Meningitis dosing error: Don't use standard 1-2 g daily dosing for meningitis - requires 2 g every 12 hours for adequate CSF penetration 1
- Staphylococcus aureus meningitis: Neither standard dosing regimen achieves adequate CSF levels for S. aureus (MIC 4 mg/L) - requires alternative therapy 6
- Chlamydia coverage: Ceftriaxone has no activity against C. trachomatis; add doxycycline for gonococcal infections when chlamydia not excluded 5, 2
Resistance Considerations
- All S. pneumoniae isolates in recent studies remain ceftriaxone-susceptible 8
- For penicillin/cephalosporin-resistant pneumococcus: continue ceftriaxone 2 g every 12 hours PLUS vancomycin 15-20 mg/kg every 12 hours PLUS rifampicin 600 mg every 12 hours 1
- Ciprofloxacin resistance in N. meningitidis increasing; use ceftriaxone for prophylaxis in high-resistance areas 9